| 0 |
POSITIONAL THERAPY |
1 |
1.0000 |
| 1 |
ACUTE MYELOID LEUKAEMIA REFRACTORY |
4 |
0.0233 |
| 2 |
MYELOBLAST COUNT INCREASED |
1 |
0.0130 |
| 3 |
MEGAKARYOCYTES DECREASED |
1 |
0.0108 |
| 4 |
LARYNGEAL HAEMORRHAGE |
1 |
0.0087 |
| 5 |
CORONARY OSTIAL STENOSIS |
1 |
0.0079 |
| 6 |
ANAEMIA OF MALIGNANT DISEASE |
2 |
0.0071 |
| 7 |
CHLOROMA |
3 |
0.0071 |
| 8 |
MITRAL VALVE SCLEROSIS |
1 |
0.0058 |
| 9 |
CLOSTRIDIAL SEPSIS |
1 |
0.0041 |
| 10 |
SYNOVIAL RUPTURE |
1 |
0.0029 |
| 11 |
ENTEROBACTER SEPSIS |
1 |
0.0027 |
| 12 |
ENDOMETRIAL HYPERTROPHY |
1 |
0.0025 |
| 13 |
DEATH OF RELATIVE |
1 |
0.0025 |
| 14 |
ENDOMETRIAL DISORDER |
1 |
0.0024 |
| 15 |
LACK OF SPONTANEOUS SPEECH |
1 |
0.0023 |
| 16 |
METASTASES TO BONE MARROW |
1 |
0.0020 |
| 17 |
LOWER RESPIRATORY TRACT INFECTION BACTERIAL |
1 |
0.0020 |
| 18 |
ACUTE MYELOID LEUKAEMIA RECURRENT |
4 |
0.0019 |
| 19 |
ENTERITIS INFECTIOUS |
3 |
0.0018 |
| 20 |
CARDIORENAL SYNDROME |
1 |
0.0017 |
| 21 |
PNEUMOCOCCAL SEPSIS |
1 |
0.0015 |
| 22 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
3 |
0.0014 |
| 23 |
DIFFERENTIATION SYNDROME |
1 |
0.0014 |
| 24 |
LIVER ABSCESS |
4 |
0.0012 |
| 25 |
PROCEDURAL HYPOTENSION |
1 |
0.0012 |
| 26 |
TRANSFUSION REACTION |
1 |
0.0011 |
| 27 |
MUSCLE SWELLING |
1 |
0.0011 |
| 28 |
FEBRILE NEUTROPENIA |
69 |
0.0010 |
| 29 |
CORONAVIRUS TEST POSITIVE |
1 |
0.0010 |
| 30 |
BLAST CELL COUNT INCREASED |
1 |
0.0010 |
| 31 |
PERIRECTAL ABSCESS |
1 |
0.0009 |
| 32 |
HAEMORRHAGIC STROKE |
7 |
0.0009 |
| 33 |
BLOODY DISCHARGE |
1 |
0.0009 |
| 34 |
OPTIC NERVE INJURY |
1 |
0.0009 |
| 35 |
ACUTE FEBRILE NEUTROPHILIC DERMATOSIS |
2 |
0.0009 |
| 36 |
HYPOCHLORAEMIA |
1 |
0.0009 |
| 37 |
FEBRILE INFECTION |
1 |
0.0008 |
| 38 |
NEUTROPENIC SEPSIS |
6 |
0.0008 |
| 39 |
CLOSTRIDIUM COLITIS |
1 |
0.0008 |
| 40 |
NEOPLASM PROGRESSION |
28 |
0.0008 |
| 41 |
PNEUMONIA FUNGAL |
3 |
0.0008 |
| 42 |
PACKED RED BLOOD CELL TRANSFUSION |
1 |
0.0008 |
| 43 |
ISCHAEMIC HEPATITIS |
1 |
0.0007 |
| 44 |
HOSPICE CARE |
7 |
0.0007 |
| 45 |
GASTRITIS HAEMORRHAGIC |
1 |
0.0007 |
| 46 |
FUNGAEMIA |
1 |
0.0006 |
| 47 |
METABOLIC ALKALOSIS |
1 |
0.0006 |
| 48 |
RESPIRATORY ALKALOSIS |
1 |
0.0006 |
| 49 |
INFLAMMATORY MARKER INCREASED |
3 |
0.0006 |
| 50 |
RECTAL ABSCESS |
1 |
0.0006 |
| 51 |
ENTEROBACTER INFECTION |
1 |
0.0006 |
| 52 |
BLOOD PH DECREASED |
1 |
0.0006 |
| 53 |
SOFT TISSUE INFECTION |
1 |
0.0005 |
| 54 |
BODY TEMPERATURE ABNORMAL |
1 |
0.0005 |
| 55 |
HYPOREFLEXIA |
1 |
0.0005 |
| 56 |
CREATININE RENAL CLEARANCE DECREASED |
2 |
0.0005 |
| 57 |
VENOUS THROMBOSIS LIMB |
1 |
0.0005 |
| 58 |
GASTROINTESTINAL PERFORATION |
2 |
0.0005 |
| 59 |
GASTROINTESTINAL ULCER |
1 |
0.0005 |
| 60 |
CALCINOSIS |
1 |
0.0004 |
| 61 |
LUMBAR VERTEBRAL FRACTURE |
2 |
0.0004 |
| 62 |
ESCHERICHIA BACTERAEMIA |
1 |
0.0004 |
| 63 |
CYTOPENIA |
5 |
0.0004 |
| 64 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
3 |
0.0004 |
| 65 |
LABYRINTHITIS |
1 |
0.0004 |
| 66 |
PHYSICAL DECONDITIONING |
1 |
0.0004 |
| 67 |
ACUTE MYELOID LEUKAEMIA |
6 |
0.0004 |
| 68 |
MUCORMYCOSIS |
1 |
0.0004 |
| 69 |
WHITE BLOOD CELL DISORDER |
1 |
0.0004 |
| 70 |
HEPATOTOXICITY |
8 |
0.0004 |
| 71 |
NEUTROPHIL COUNT ABNORMAL |
1 |
0.0004 |
| 72 |
HERPES VIRUS INFECTION |
2 |
0.0003 |
| 73 |
ESCHERICHIA SEPSIS |
1 |
0.0003 |
| 74 |
BACTERAEMIA |
4 |
0.0003 |
| 75 |
ELECTROCARDIOGRAM QT PROLONGED |
12 |
0.0003 |
| 76 |
METABOLIC ENCEPHALOPATHY |
1 |
0.0003 |
| 77 |
VENTRICULAR HYPOKINESIA |
1 |
0.0003 |
| 78 |
ANTINUCLEAR ANTIBODY POSITIVE |
1 |
0.0003 |
| 79 |
BACTERIAL SEPSIS |
1 |
0.0003 |
| 80 |
LYMPHOCYTE COUNT INCREASED |
1 |
0.0003 |
| 81 |
MUCOSAL INFLAMMATION |
8 |
0.0003 |
| 82 |
SUPRAVENTRICULAR EXTRASYSTOLES |
1 |
0.0003 |
| 83 |
HYPERBILIRUBINAEMIA |
3 |
0.0003 |
| 84 |
CLOSTRIDIUM DIFFICILE COLITIS |
3 |
0.0003 |
| 85 |
FOOD INTOLERANCE |
1 |
0.0003 |
| 86 |
BRONCHOPULMONARY ASPERGILLOSIS |
2 |
0.0003 |
| 87 |
PULMONARY HAEMORRHAGE |
2 |
0.0003 |
| 88 |
SEPTIC SHOCK |
11 |
0.0003 |
| 89 |
FEBRILE BONE MARROW APLASIA |
1 |
0.0002 |
| 90 |
ESCHERICHIA URINARY TRACT INFECTION |
1 |
0.0002 |
| 91 |
MYOPATHY |
2 |
0.0002 |
| 92 |
VASCULAR DEVICE INFECTION |
1 |
0.0002 |
| 93 |
BLOOD PRESSURE SYSTOLIC DECREASED |
1 |
0.0002 |
| 94 |
ROSACEA |
1 |
0.0002 |
| 95 |
NON-SMALL CELL LUNG CANCER |
1 |
0.0002 |
| 96 |
GASTROINTESTINAL TOXICITY |
1 |
0.0002 |
| 97 |
ATELECTASIS |
2 |
0.0002 |
| 98 |
ENTEROCOCCAL INFECTION |
1 |
0.0002 |
| 99 |
STAPHYLOCOCCAL SEPSIS |
1 |
0.0002 |
| 100 |
HYPERVOLAEMIA |
1 |
0.0002 |
| 101 |
CORONARY ARTERY STENOSIS |
1 |
0.0002 |
| 102 |
BLOOD COUNT ABNORMAL |
3 |
0.0002 |
| 103 |
TASTE DISORDER |
4 |
0.0002 |
| 104 |
PARTIAL SEIZURES |
1 |
0.0002 |
| 105 |
BLOOD LACTIC ACID INCREASED |
1 |
0.0002 |
| 106 |
GASTROINTESTINAL MOTILITY DISORDER |
1 |
0.0002 |
| 107 |
PRODUCT RESIDUE PRESENT |
1 |
0.0002 |
| 108 |
STRESS FRACTURE |
1 |
0.0002 |
| 109 |
GASTRIC ULCER HAEMORRHAGE |
1 |
0.0002 |
| 110 |
NEUTROPENIA |
24 |
0.0002 |
| 111 |
MYOCARDITIS |
2 |
0.0002 |
| 112 |
ENTEROCOLITIS |
1 |
0.0002 |
| 113 |
METABOLIC DISORDER |
1 |
0.0002 |
| 114 |
HYPOVOLAEMIA |
1 |
0.0002 |
| 115 |
COVID-19 PNEUMONIA |
2 |
0.0002 |
| 116 |
OLIGURIA |
1 |
0.0002 |
| 117 |
ACUTE RESPIRATORY FAILURE |
3 |
0.0002 |
| 118 |
C-REACTIVE PROTEIN ABNORMAL |
1 |
0.0002 |
| 119 |
PROCTALGIA |
1 |
0.0002 |
| 120 |
TENDON DISORDER |
1 |
0.0002 |
| 121 |
TERMINAL STATE |
1 |
0.0001 |
| 122 |
LEFT VENTRICULAR DYSFUNCTION |
1 |
0.0001 |
| 123 |
FULL BLOOD COUNT DECREASED |
3 |
0.0001 |
| 124 |
PNEUMONIA |
48 |
0.0001 |
| 125 |
JOINT EFFUSION |
1 |
0.0001 |
| 126 |
HYPERTRANSAMINASAEMIA |
1 |
0.0001 |
| 127 |
PANCYTOPENIA |
8 |
0.0001 |
| 128 |
RIGHT VENTRICULAR FAILURE |
1 |
0.0001 |
| 129 |
HYPONATRAEMIA |
8 |
0.0001 |
| 130 |
SUBDURAL HAEMATOMA |
2 |
0.0001 |
| 131 |
GRAFT VERSUS HOST DISEASE |
1 |
0.0001 |
| 132 |
MYELOSUPPRESSION |
5 |
0.0001 |
| 133 |
UTERINE LEIOMYOMA |
1 |
0.0001 |
| 134 |
HYPOPHOSPHATAEMIA |
1 |
0.0001 |
| 135 |
SEPSIS |
15 |
0.0001 |
| 136 |
PAROSMIA |
1 |
0.0001 |
| 137 |
TROPONIN INCREASED |
1 |
0.0001 |
| 138 |
DEATH |
111 |
0.0001 |
| 139 |
POST PROCEDURAL INFECTION |
1 |
0.0001 |
| 140 |
SECOND PRIMARY MALIGNANCY |
1 |
0.0001 |
| 141 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
2 |
0.0001 |
| 142 |
CIRCULATORY COLLAPSE |
2 |
0.0001 |
| 143 |
DRUG RESISTANCE |
3 |
0.0001 |
| 144 |
BLOOD MAGNESIUM DECREASED |
1 |
0.0001 |
| 145 |
SPINAL OSTEOARTHRITIS |
1 |
0.0001 |
| 146 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
2 |
0.0001 |
| 147 |
HAEMARTHROSIS |
1 |
0.0001 |
| 148 |
BLOOD BILIRUBIN INCREASED |
3 |
0.0001 |
| 149 |
OSTEOMYELITIS |
2 |
0.0001 |
| 150 |
PNEUMONITIS |
3 |
0.0001 |
| 151 |
RESPIRATORY DISTRESS |
3 |
0.0001 |
| 152 |
NERVE COMPRESSION |
1 |
0.0001 |
| 153 |
ARTERIOSCLEROSIS |
1 |
0.0001 |
| 154 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
3 |
0.0001 |
| 155 |
COLITIS |
4 |
0.0001 |
| 156 |
HAEMATOTOXICITY |
1 |
0.0001 |
| 157 |
SLEEP APNOEA SYNDROME |
2 |
0.0001 |
| 158 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
3 |
0.0001 |
| 159 |
RENAL TUBULAR NECROSIS |
1 |
0.0001 |
| 160 |
ACUTE MYOCARDIAL INFARCTION |
3 |
0.0001 |
| 161 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
1 |
0.0001 |
| 162 |
VENTRICULAR EXTRASYSTOLES |
1 |
0.0001 |
| 163 |
TRANSFUSION |
1 |
0.0001 |
| 164 |
FOLLICULITIS |
1 |
0.0001 |
| 165 |
SUDDEN DEATH |
1 |
0.0001 |
| 166 |
TRANSAMINASES INCREASED |
2 |
0.0001 |
| 167 |
MITRAL VALVE INCOMPETENCE |
1 |
0.0001 |
| 168 |
NEOPLASM |
1 |
0.0001 |
| 169 |
DELIRIUM |
3 |
0.0001 |
| 170 |
ELECTROLYTE IMBALANCE |
1 |
0.0001 |
| 171 |
HYPOXIA |
3 |
0.0001 |
| 172 |
PLATELET COUNT DECREASED |
9 |
0.0001 |
| 173 |
PRODUCT PRESCRIBING ERROR |
2 |
0.0001 |
| 174 |
CHOLECYSTITIS |
1 |
0.0001 |
| 175 |
POLYNEUROPATHY |
1 |
0.0001 |
| 176 |
GENERALISED OEDEMA |
1 |
0.0001 |
| 177 |
DYSGEUSIA |
6 |
0.0001 |
| 178 |
TOXICITY TO VARIOUS AGENTS |
13 |
0.0001 |
| 179 |
RESPIRATORY TRACT INFECTION |
2 |
0.0001 |
| 180 |
BLOOD CREATININE INCREASED |
5 |
0.0001 |
| 181 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
3 |
0.0001 |
| 182 |
GINGIVAL BLEEDING |
1 |
0.0001 |
| 183 |
DIVERTICULITIS |
2 |
0.0001 |
| 184 |
MENTAL STATUS CHANGES |
2 |
0.0001 |
| 185 |
ORAL DISCOMFORT |
1 |
0.0001 |
| 186 |
THROMBOCYTOPENIA |
8 |
0.0001 |
| 187 |
DISSEMINATED INTRAVASCULAR COAGULATION |
1 |
0.0001 |
| 188 |
RECTAL HAEMORRHAGE |
3 |
0.0001 |
| 189 |
INFECTION |
10 |
0.0001 |
| 190 |
PULMONARY ARTERIAL HYPERTENSION |
1 |
0.0001 |
| 191 |
HYPOKINESIA |
1 |
0.0001 |
| 192 |
COMPLICATION ASSOCIATED WITH DEVICE |
1 |
0.0001 |
| 193 |
FLUID OVERLOAD |
1 |
0.0001 |
| 194 |
IMMUNODEFICIENCY |
1 |
0.0001 |
| 195 |
HAEMORRHAGE INTRACRANIAL |
1 |
0.0001 |
| 196 |
MUSCULOSKELETAL CHEST PAIN |
1 |
0.0001 |
| 197 |
LUNG INFECTION |
1 |
0.0001 |
| 198 |
CYANOSIS |
1 |
0.0001 |
| 199 |
PRODUCT USE COMPLAINT |
1 |
0.0001 |
| 200 |
FUNGAL INFECTION |
2 |
0.0001 |
| 201 |
DISEASE PROGRESSION |
7 |
0.0001 |
| 202 |
ORTHOSTATIC HYPOTENSION |
1 |
0.0001 |
| 203 |
CEREBRAL HAEMORRHAGE |
2 |
0.0001 |
| 204 |
TOOTHACHE |
1 |
0.0001 |
| 205 |
TREATMENT NONCOMPLIANCE |
3 |
0.0001 |
| 206 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 207 |
CYTOKINE RELEASE SYNDROME |
1 |
0.0000 |
| 208 |
BONE MARROW FAILURE |
1 |
0.0000 |
| 209 |
NEUTROPHIL COUNT DECREASED |
2 |
0.0000 |
| 210 |
PERITONITIS |
1 |
0.0000 |
| 211 |
PULMONARY HYPERTENSION |
1 |
0.0000 |
| 212 |
ACUTE KIDNEY INJURY |
7 |
0.0000 |
| 213 |
GLOSSODYNIA |
1 |
0.0000 |
| 214 |
PRODUCT USE IN UNAPPROVED INDICATION |
11 |
0.0000 |
| 215 |
HYPOKALAEMIA |
2 |
0.0000 |
| 216 |
UPPER RESPIRATORY TRACT INFECTION |
2 |
0.0000 |
| 217 |
DECREASED APPETITE |
10 |
0.0000 |
| 218 |
PRODUCT USE ISSUE |
8 |
0.0000 |
| 219 |
LOCALISED INFECTION |
1 |
0.0000 |
| 220 |
PRESYNCOPE |
1 |
0.0000 |
| 221 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 222 |
AGEUSIA |
1 |
0.0000 |
| 223 |
CELLULITIS |
2 |
0.0000 |
| 224 |
HAEMATEMESIS |
1 |
0.0000 |
| 225 |
HYPOPHAGIA |
1 |
0.0000 |
| 226 |
HAEMOGLOBIN DECREASED |
4 |
0.0000 |
| 227 |
OFF LABEL USE |
34 |
0.0000 |
| 228 |
ARTHRITIS |
3 |
0.0000 |
| 229 |
HAEMATOCHEZIA |
2 |
0.0000 |
| 230 |
TREATMENT FAILURE |
3 |
0.0000 |
| 231 |
CEREBROVASCULAR ACCIDENT |
6 |
0.0000 |
| 232 |
SEIZURE |
4 |
0.0000 |
| 233 |
DYSSTASIA |
1 |
0.0000 |
| 234 |
ASCITES |
1 |
0.0000 |
| 235 |
CORONARY ARTERY DISEASE |
1 |
0.0000 |
| 236 |
NERVOUS SYSTEM DISORDER |
1 |
0.0000 |
| 237 |
DRUG-INDUCED LIVER INJURY |
1 |
0.0000 |
| 238 |
ATRIAL FIBRILLATION |
3 |
0.0000 |
| 239 |
URINARY RETENTION |
1 |
0.0000 |
| 240 |
MALIGNANT NEOPLASM PROGRESSION |
3 |
0.0000 |
| 241 |
PYREXIA |
10 |
0.0000 |
| 242 |
WHITE BLOOD CELL COUNT DECREASED |
3 |
0.0000 |
| 243 |
C-REACTIVE PROTEIN INCREASED |
1 |
0.0000 |
| 244 |
RESPIRATORY FAILURE |
2 |
0.0000 |
| 245 |
UNDERDOSE |
2 |
0.0000 |
| 246 |
EPISTAXIS |
2 |
0.0000 |
| 247 |
ANAEMIA |
5 |
0.0000 |
| 248 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 249 |
GENERAL PHYSICAL HEALTH DETERIORATION |
3 |
0.0000 |
| 250 |
ABNORMAL BEHAVIOUR |
1 |
0.0000 |
| 251 |
DISORIENTATION |
1 |
0.0000 |
| 252 |
CONFUSIONAL STATE |
4 |
0.0000 |
| 253 |
GASTROINTESTINAL HAEMORRHAGE |
2 |
0.0000 |
| 254 |
OSTEOARTHRITIS |
1 |
0.0000 |
| 255 |
HYPOACUSIS |
1 |
0.0000 |
| 256 |
VAGINAL HAEMORRHAGE |
1 |
0.0000 |
| 257 |
CONSTIPATION |
5 |
0.0000 |
| 258 |
RENAL FAILURE |
3 |
0.0000 |
| 259 |
TACHYCARDIA |
2 |
0.0000 |
| 260 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
0.0000 |
| 261 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
| 262 |
MUSCLE SPASMS |
4 |
0.0000 |
| 263 |
ARRHYTHMIA |
1 |
0.0000 |
| 264 |
DYSPHAGIA |
2 |
0.0000 |
| 265 |
LEUKOPENIA |
1 |
0.0000 |
| 266 |
HYPOTENSION |
4 |
0.0000 |
| 267 |
THERAPY CESSATION |
1 |
0.0000 |
| 268 |
ILLNESS |
2 |
0.0000 |
| 269 |
PANCREATITIS |
1 |
0.0000 |
| 270 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 271 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 272 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 273 |
MUSCULAR WEAKNESS |
2 |
0.0000 |
| 274 |
URINARY TRACT INFECTION |
3 |
0.0000 |
| 275 |
NASAL CONGESTION |
1 |
0.0000 |
| 276 |
PLEURAL EFFUSION |
1 |
0.0000 |
| 277 |
ALOPECIA |
3 |
0.0000 |
| 278 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 279 |
DEHYDRATION |
2 |
0.0000 |
| 280 |
WEIGHT DECREASED |
4 |
0.0000 |
| 281 |
THERAPY INTERRUPTED |
1 |
0.0000 |
| 282 |
DIARRHOEA |
9 |
0.0000 |
| 283 |
HALLUCINATION |
1 |
0.0000 |
| 284 |
UNEVALUABLE EVENT |
1 |
0.0000 |
| 285 |
BACK PAIN |
3 |
0.0000 |
| 286 |
DRUG INTERACTION |
2 |
0.0000 |
| 287 |
CARDIAC FAILURE CONGESTIVE |
1 |
0.0000 |
| 288 |
CARDIAC ARREST |
1 |
0.0000 |
| 289 |
ABDOMINAL DISCOMFORT |
2 |
0.0000 |
| 290 |
MYALGIA |
2 |
0.0000 |
| 291 |
MALAISE |
5 |
0.0000 |
| 292 |
CARDIAC DISORDER |
1 |
0.0000 |
| 293 |
SWELLING |
1 |
0.0000 |
| 294 |
ASTHENIA |
4 |
0.0000 |
| 295 |
PULMONARY EMBOLISM |
1 |
0.0000 |
| 296 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 297 |
GAIT DISTURBANCE |
2 |
0.0000 |
| 298 |
DRUG INTOLERANCE |
1 |
0.0000 |
| 299 |
NAUSEA |
8 |
0.0000 |
| 300 |
SYNCOPE |
1 |
0.0000 |
| 301 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 302 |
ARTHRALGIA |
4 |
0.0000 |
| 303 |
ABDOMINAL DISTENSION |
1 |
0.0000 |
| 304 |
INFLUENZA |
1 |
0.0000 |
| 305 |
DEPRESSION |
2 |
0.0000 |
| 306 |
ABDOMINAL PAIN |
2 |
0.0000 |
| 307 |
DRUG INEFFECTIVE |
10 |
0.0000 |
| 308 |
PRODUCT DOSE OMISSION ISSUE |
2 |
0.0000 |
| 309 |
CONDITION AGGRAVATED |
2 |
0.0000 |
| 310 |
HOSPITALISATION |
1 |
0.0000 |
| 311 |
FATIGUE |
5 |
0.0000 |
| 312 |
TREMOR |
1 |
0.0000 |
| 313 |
FALL |
2 |
0.0000 |
| 314 |
URTICARIA |
1 |
0.0000 |
| 315 |
NO ADVERSE EVENT |
1 |
0.0000 |
| 316 |
CHEST PAIN |
1 |
0.0000 |
| 317 |
ERYTHEMA |
1 |
0.0000 |
| 318 |
HYPERTENSION |
1 |
0.0000 |
| 319 |
DIZZINESS |
2 |
0.0000 |
| 320 |
DYSPNOEA |
2 |
0.0000 |
| 321 |
RASH |
1 |
0.0000 |
| 322 |
VOMITING |
1 |
0.0000 |
| 323 |
PAIN |
1 |
0.0000 |
| 324 |
HEADACHE |
1 |
0.0000 |